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Crop improvement can be viewed as a continuum that was ini-
tiated millennia ago when humans first domesticated, selected
and cultivated plants. It progressed through the use of: animal
power to make agricultural practices more efficient; Mendelian
genetics that has put conventional plant breeding on a scientif-
ic footing; machines during and after the industrial revolution;
chemical mutagens and ionizing radiation to create novel (use-
ful) variability in existing germplasm; chemical assistance dur-
ing the Green Revolution in the form of fertilizers and crop pro-
tection chemicals; and finally, plant biotechnology. The
interesting thing about plant biotechnology and the use of
transgenic plants in modern agriculture is that crop improve-
ment can now be accomplished a lot more efficiently and
quickly, often eliminating expensive and environmentally harm-
ful practices and chemical inputs from the agricultural produc-
tion chain. Because of the enormous potential of transgenic
plants to revolutionize agriculture, the science and technology
of the process have been closely linked to issues of world
trade, protectionism, globalization, food safety and intellectual
property. It has played into the hands of dubious so-called “en-
vironmental” organizations that have their own agendas in try-
ing to block this technology from reaching the people, such as
poor subsistence farmers in the developing world, who need
its benefits the most.
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Resum
Les plantes transgèniques són una part integral de l’agricultura
contemporània. Durant l’any 2006 més de noranta milions
d’hectàrees de plantes transgèniques van ser cultivades en
vint-i-un països. Des de la comercialització de la primera planta
transgènica el 1996 els nivells d’adopció d’aquests cultius han
augmentat anualment amb percentatges de dos dígits. El de -
senvolupament i la comercialització de les plantes transgèni-
ques van lligats estretament al comerç mundial, a la globalitza-
ció, a la disponibilitat de suficient menjar, a la protecció del
medi ambient i del consumidor i a la propietat intel·lectual. En
aquest article exposem els avenços més recents i les tendèn-
cies actuals en el desenvolupament dels cultius transgènics i
de la seva utilització. També ens fem ressò d’alguns assump-
tes no científics que s’han de solucionar abans que aquests
cultius arribin al màxim del seu potencial, proporcionant una
agricultura més sostenible i ecològica. Finalment, ressaltarem
la importància de com les plantes transgèniques poden contri-
buir en la disponibilitat de menjar i en la millora de la pobresa en
els països en vies de desenvolupament.
Abstract
Transgenic plants are now an integral part of contemporary
agriculture. Globally, more than 90 million Ha of transgenic
crops were grown in twenty-one countries during 2006. Dou-
ble-digit percentage increases in annual adoption rates have
been recorded every year since the commercialization of the
first transgenic crops in 1996. The development and commer-
cialization of transgenic plants is closely linked to world trade,
globalization, food safety, environmental and consumer pro-
tection and intellectual property. In this article, we discuss re-
cent advances and current trends in transgenic crop develop-
ment and their deployment. We also address some of the
non-scientific issues that need to be resolved before these
crops can develop their full potential in order to deliver more
sustainable and environmentally friendly agriculture. Finally, we
will highlight the importance of transgenic crops in contributing
towards food security and alleviating poverty in the developing
world.
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Historical background 
Plant genetic modification requires efficient, easy gene transfer
methods that will be generally applicable to as many plant
species and genotypes as possible [1]. This is important once
we move from model laboratory plant species, such as Ara-
bidopsis thaliana and Nicotiana tabaccum, to cultivated crops.
Divergence in the molecular mechanisms through which differ-
ent plants express transgenes, make it necessary to design
appropriate genetic constructs with different promoter ele-
ments, introns or enhancers, for example in monocotyledo-
nous versus dicotyledonous plants. The delivery and stable in-
tegration of foreign genes into plant cells is the first step
towards the creation of transgenic plants [2]. Once foreign
genes are integrated into the host genome, they need to be
translated and transcribed. The resulting gene products, e.g.
proteins, enzymes, hormones, etc., need to be stably ex-
pressed over subsequent generations in a predictable fashion.
Investigations of mechanisms and factors that influence prop-
er transgene expression have been the subject of intense
study [3]. Such studies focusing on transgene silencing have
resulted in the development of highly sophisticated models
that attempt to provide a rational basis for the occasional
aberrant expression of transgenes that are integrated into the
plant genome. In turn, such experiments form the basis of im-
proved strategies for creating transgenic plants that stably ex-
press introduced transgenes. Additional factors that con-
tribute to transgene-expression stability (or instability) are
being investigated and such studies are now beginning to re-
veal the importance of how a transgenic locus is organized fol-
lowing gene transfer [4]. 
Current trends in transgenic crop development
The development of transgenic technology continues to ex-
pand into increasing numbers of crops and introduced traits
[5]. The focus remains on the major field crops of soybean,
maize, cotton, oilseed rape, rice and potato, with introduced
genes conferring herbicide tolerance and/or pest resistance.
Second and third generation transgenic plants include plants
that are currently in the production, or research and develop-
ment pipelines and are expected to reach commercialization in
the next five to ten years [6]. In addition to “stacked traits” com-
bining insect resistance and herbicide tolerance in the same
crop, further traits include food quality and nutritional enhance-
ment (e.g. plants with increased levels of bio-available iron and
enhanced vitamin content); productivity increases through the
manipulation of physiological (e.g. photosynthetic rate and im-
proved nitrogen uptake) and biochemical (e.g. plants with al-
tered metabolic profiles for non-food applications) characters;
tolerances to abiotic stress (e.g. plants that are better able to
survive and proliferate under extreme environmental conditions
or on marginal soils); development of plants for the production
of pharmaceuticals for human and veterinary applications; and
plants that contribute to environmentally-friendly agriculture
and sustainability to name just a few. Ultimately we are looking
at the development of crop plants with enhanced yield poten-
tial, better adaptability to water and nutrient uptake, leading to
more sustainable and southern hemisphere, concern many
plant biotechnologists and policy makers, and this is an area
where major, positive impacts of second- and third-generation
transgenic crops are beginning to bear fruit, and are expected
to contribute even more substantially. 
The new frontier: second and third generation
transgenic plants
Second-generation insect-resistant transgenic plants with in-
creased potential for durable resistance might result from the
deployment of plants expressing multiple insecticidal proteins.
We earlier reported the simultaneous introduction of three
genes expressing insecticidal proteins, Cry1Ac, Cry2A and
Gna, into indica rice to control three major pest, rice leaf folder
(Cnaphalocrocis medinalis), yellow stemborer (Scirpophaga in-
certulas) and the brown planthopper (Nilaparvata lugens) [7].
The Bacillus thuringiensis (Bt) genes target the leaf folder and
the stem borer, and the Gna gene targets planthoppers. Trans-
genic plants were more resistant compared to their binary
counterparts. Plants engineered with a fusion protein combin-
ing Cry1Ac with the galactose-binding domain of the non-toxic
ricin B-chain provide the toxin with additional binding domains,
thus increasing the potential number of interactions at molecu-
lar level in target insects. Transgenic rice and maize plants en-
gineered to express the fusion protein were significantly more
toxic in insect bioassays than those containing the Bt gene
alone [8]. They were also resistant to attack by a wider range of
insects, including important pests that are not normally sus-
ceptible to Bt toxins. The recognition of toxin binding sites in
the insect midgut is an important factor determining the spec-
trum of Bt toxin activity and severity of toxaemia [8 and refer-
ences therein].
Abiotic stresses, such as drought, represent some of the
most significant constraints on agricultural productivity. Trans-
genic approaches can be used in combination with conven-
tional breeding to create crops with enhanced drought toler-
ance, and one way in which this can be achieved is through
the manipulation of polyamine metabolism. Polyamines are
small, ubiquitous, nitrogenous compounds that have been im-
plicated in a variety of stress responses in plants [9]. The link
between polyamines and abiotic stress was first documented
through putrescine accumulation in response to sub-optimal
potassium levels in barley [10]. Since then, a link has been
suggested between increased putrescine levels and abiotic
stress. Similar phenomena have been described in animals,
e.g. during ischemic and post-ischemic responses in neurons
[11]. The genetic manipulation of polyamine metabolism has
become a valuable tool for studying their physiological roles in
plants. Plant polyamine content has been modulated by the
over-expression/down-regulation of arginine decarboxylase
(adc), ornithine decarboxylase (odc) and S-adenosylmethion-
ine decarboxylase (samdc) [12 – 17]. Over-expression of het-
erologous adc or odc cDNAs in plants generally results in the
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production of high levels of putrescine [14, 15]. In most cases,
this is accompanied by a relatively small increase in spermi-
dine and spermine concentrations. Such findings suggest that
the levels of spermidine and spermine are under strict homeo-
static regulation. Therefore, the study of plants transformed
with genes involved in polyamine biosynthesis may shed light
on the importance of polyamines, their role in the acquisition of
stress tolerance and relevant stress tolerance mechanisms.
We have generated transgenic rice plants expressing the
Datura stramonium adc gene (Figure 1) and investigated their
response to drought stress induced by 20% polyethylene gly-
col (PEG). We monitored the steady-state mRNA levels of
genes involved in polyamine biosynthesis (Datura adc, rice adc
and rice samdc) and polyamine levels. Wild type plants re-
sponded to the onset of drought stress by increasing endoge-
nous putrescine levels, but this was insufficient to trigger the
conversion of putrescine into spermidine and spermine (the
agents that are believed to protect plants under stress). In con-
trast, transgenic plants expressing Datura adc produced much
higher levels of putrescine under stress, promoting spermidine
and spermine synthesis and ultimately protecting the plants
from drought. We clearly demonstrated that the manipulation
of polyamine biosynthesis in plants can produce drought-toler-
ant germplasm, and we proposed a model consistent with the
role of polyamines in the protection of plants against abiotic
stress.
Proteins can be used as diagnostic reagents, vaccines and
drugs, and this creates a strong demand for the production of
recombinant proteins on an industrial scale. Commercial pro-
tein production has traditionally relied on microbial fermenta-
tion and mammalian cell culture, but these systems have dis-
advantages in terms of cost, scalability and safety that have
prompted research into alternative production platforms [18].
Despite industry inertia and conservatism, plants have
emerged as one of the most promising general production
platforms for tomorrow’s biologics. Plants allow the cost-ef-
fective production of recombinant proteins on an agricultural
scale, while eliminating risk of product contamination with en-
dotoxins or human pathogens [19]. Another advantage of 
the use of plants in recombinant protein production is that
vaccine candidates can be expressed in edible plant organs,
allowing them to be administered as unprocessed or partially
processed material [18]. Four cereal crops – maize, rice, barley
and wheat – have been used as seed-based production sys-
tems and the first three are being developed commercially.
Maize has the highest annual grain yield of the four, moderate-
ly high seed protein content and the shortest generation inter-
val, giving the highest potential protein yield per hectare [re-
viewed in 20]. Maize also benefits from the relative ease of in
vitro manipulation and transformation, and the availability of
several useful seed-specific promoters that can be used to dri-
ve transgene expression [Figure 2; 21]. Maize was used to
produce the first two commercial plant-derived recombinant
proteins, avidin and β-glucuronidase [22]. Maize has also been
investigated as a commercial platform by several other parties
for the production of a range of pharmaceutical and technical
proteins, including recombinant antibodies, vaccine candi-
dates and enzymes [22 –24]. Maize is also the main vehicle for
the production of recombinant pharmaceuticals against
HIV/AIDS, tuberculosis, diabetes and rabies, within the Phar-
ma-Planta FP6 Integrated project. For more details please see
www.Pharma-Planta.org.
Reverse genetics methods for the functional analysis of
genes discovered by genome sequencing are well developed.
Insertional mutagenesis using T-DNA or transposons is one of
the tools for functional analysis to elucidate gene function, but
collaborative investments are required for such large-scale ef-
forts targeting elucidation of all gene functions. In several or-
ganisms like Drosophila, Caenorhabiditis and even Arabidop-
sis, saturated insertional mutagenesis has been used, first to
create a library of insertion mutants and then to select inser-
tions in genes of interest using PCR based screens [25]. How-
ever, with larger genomes, saturated mutagenesis is more dif-
ficult to achieve, and it is not cost-effective to screen for
inserts in a gene for gene approach. The alternative strategy
has been to sequence DNA flanking insertion sequences and
A B
Figure 1. Transgenic rice seedlings (A) and mature flowering plant (B),
harbouring the Datura stamonium arginine decarboxylase cDNA.
A B C
D E F
Figure 2. Corn transformation. (A) Corn embryogenic callus; (B) regen-
erating shoots; (C) shoots on selection media; (D) transgenic corn
seedling; (E) transgenic corn plants; (D) seeds expressing HIV-neutral-
izing antibody.
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catalogue these in relation to annotated genes on the genome
sequence. Several initiatives to generate large rice insertional
mutant collections have been initiated [26] and the databases
of insertion flanking sequences are becoming available in the
public domain [27; 28]. We took part in a European Consor-
tium starting in 1997 with the aim of developing heterologous
transposon mutagenesis strategies for functional genomics in
rice [29]. Enhancer trap gene detection constructs using the
two-component Ac/Ds transposon system were introduced
into japonica rice and a collection of starter lines were devel-
oped [30]. In general the Ac/Ds system exhibited high mobility
in rice, although inactivation of Ds was observed in later gener-
ations (Figure 3). The high frequency of T1 progeny plants with
independent insertions allowed the effective use of the two-
component Ac/Ds lines for gene tagging, despite the reduced
mobility of Ds in later generations. As the diversity in the T2 in-
sertion pool appeared to be related to the initial number of dif-
ferent T0 regenerants and therefore T1 families propagated, a
large population of early generation plants was produced to
generate large numbers of independent stabilized insertions.
The T2 and T3 lines generated thus provide a collection of sta-
ble insertions that can be directly used for reverse genetic
screenings. 
The consortium reported the production of a collection of
about 1000 unique flanking sequence tags (FSTs) from japoni-
ca and indica rice generated from Ac and Ac-Ds transposon
lines for reverse genetics in rice. On comparison to public data-
bases, the FSTs were assigned a position in the rice genome
sequence represented by assembled chromosome pseudo-
molecules. The inserts were distributed fairly evenly over the
genome but were higher in gene-rich regions characterized by
cDNAs positioned on the chromosomes. The bias of the Ac
and Ds transposon inserts for genes was exemplified by the
presence of 57% of the inserts in genes annotated on rice
chromosomes and 40% present in genes transcribed as dis-
closed by their homology to cDNA clones. In a screening for in-
serts in a set of 65 well-annotated transcription factors, includ-
ing homeobox-containing genes, 4 inserts were found. This
high frequency of Ac and Ds inserts in genes suggests that
knockout mutagenesis will be efficient and possible with a low-
er number of inserts than expected. These FSTs and the corre-
sponding plant lines are publicly available through databases
and from EU consortium members [31].
Political dimension, impact and regulation
In an ideal world, everyone would have secure access to an
adequate supply of safe and nutritious food. This is something
that Western societies take for granted, given the seemingly
unlimited quantity and variety of fresh produce available on su-
permarket shelves. In the developing world, however, 840 mil-
lion people are chronically undernourished, surviving on fewer
than 2000 calories per day [32]. Many more people, perhaps
half of the world’s population in total, suffer from diseases
caused by dietary deficiencies and inadequate supplies of vita-
mins and minerals. It is therefore not surprising that contempo-
rary plant biotechnology stands to benefit huge numbers of
people in the developing world, to a much greater extent than
consumers in the affluent west. Perhaps this is one of the rea-
sons why well-fed Europeans, who enjoy very high living stan-
dards and qualities of life, can afford to reject technologies in
the short term, based on ideology and vested economic and
political interests.
All transgenic plants are required to undergo thorough and
rigorous safety and risk assessment before commercialization.
Regulation, amongst other things, is an important component
of transgenic crop development and field deployment as it pro-
vides de facto assurance to the public that all products ap-
proved for commercial release, are at least as safe as their non-
transgenic counterparts [33].
Intellectual property issues (IPR)
Most countries have legally established that it is reasonable for
an inventor to be given a monopoly, or the right to exclude oth-
ers from the sale or use of the invention for a limited time, in re-
turn for a full public disclosure of how the invention has been
made. In economic terms, this right of exclusivity is important
because it allows the inventor to recover the research invest-
ment while not giving competitors free access to the newly cre-
ated intellectual knowledge [34]. That said, public disclosure of
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Figure 3. DNA analysis of Ac transposition (A) genomic DNA gel blot
analysis of plants containing the Ac transposon; (B) native Ac system in
corn and phenotype resulting from transposition.
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the patent. Intellectual property rights are covered by an inter-
national treaty: Trade-Related Aspects of Intellectual Property
Rights (TRIPS). The treaty obliges member states to protect,
through patents, inventions of any product or process, in any
field of technology, assuming such inventions are novel, non-
obvious and useful, i.e. capable of commercial exploitation.
TRIPS provide grounds for exclusion in granting patent protec-
tion on moral, ethical and other grounds. Such exclusions are
non-uniform across different territories and this causes great
confusion in applying the terms of the treaty. A number of dif-
ferent vehicles exist for protecting plant-related inventions:
plant variety protection, US plant patents and utility patents.
The process of creating a transgenic plant is a multi-compo-
nent enterprise and very often, each individual component
might be the subject of IP protection. Claims may be directed
towards explants used for transformation, the vectors and ge-
netic constructs, transformation procedures, and selectable
and/or screenable markers. Early plant biotechnology patents
provided inventors with very a broad claim protection. Howev-
er, a number of these early patents have been challenged in
court and some have been overturned. It is now becoming in-
creasingly difficult to obtain a patent with a broad scope of
claims. 
An issue that is pertinent to IP protection concerns plants
and other biotechnology products or processes for humanitar-
ian use, specifically for developing country applications. Prece-
dence exists for at least two examples which pave the way for
making IP protection and humanitarian use compatible, rather
than mutually exclusive. One example is “Golden Rice”, a vari-
ety of rice engineered with the vitamin A pathway genes that
accumulates beta carotene. The creators of this rice strain
were able to convince all the holders of the IP that was used for
the creation of “Golden Rice” to donate all the relevant IPs in
order to allow the freedom to operate (FTO) for developing
countries. The consequence of this agreement is that there are
no IP constraints on “Golden Rice” and therefore, this material
can be freely distributed to the people who need it most, i.e.
people in the developing world who are deficient in vitamin A.
The second example is provided by the Pharma-Planta EU
project, a consortium of 39 different laboratories in Europe and
South Africa working on plant-made pharmaceuticals, fo-
cussing on HIV/AIDS, tuberculosis, diabetes and rabies. All
members of the project have signed a humanitarian statement
which guarantees FTO for the products and the technology de-
rived from the project, for humanitarian use in developing
countries. 
Concluding remarks
In industrialized countries, the key benefits of transgenic plants
include more environmentally friendly and sustainable agricul-
tural production practices obtained by limiting the number of
chemical inputs that are required in conventional agriculture.
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Figure 4. Potential of transgenic plants to contribute towards food security (Christou and Twyman, 2004)
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Genetically enhanced crops have the potential to address
some of the causes of hunger in the developing world, both di-
rectly (by increasing the availability of food) and indirectly (by re-
ducing poverty in developing countries) [Figure 4; 35]. Crop
failure due to pests and diseases, could be averted by adopt-
ing plants that are resistant to such biotic stresses. The devel-
opment of plants that are tolerant of extreme environments
could allow marginal soils to be brought into agricultural use,
and could allow plants to survive periods of drought or flood-
ing. The modification of plant architecture could increase yields
and sturdiness by diverting biomass from stems and stalks, to
the edible organs. Overall yields could be increased by manip-
ulating photosynthesis, carbon and nitrogen metabolism or
modifying plant development to promote early flowering, and
multiple growth cycles per year. Exhausted soils could be
sown with crops that are better able to extract nutrients, and
contaminated soils could be regenerated by plants developed
for bioremediation. These measures, in combination with con-
ventional breeding and developments in other agricultural
practices, may produce the estimated 50% increase in grain
yields required over the next 50 years to cope with the antici-
pated increase in the global population. Overwhelming evi-
dence has demonstrated the benefits of early generation trans-
genic crops in terms of increased yields and reduced chemical
inputs, despite claims of special interest groups that such early
products did not provide any benefits to consumers [36 – 38].
Knock-on effects include improved farmer and consumer
health and a cleaner environment. The future security of food-
supplies depends in part, on science providing the tools to al-
low efficient agricultural production, which is sustainable in
every sense; furthermore, sustainability of food production has
to be considered seriously and not be used as a political slogan
by so called “concerned consumers” and environmental or po-
litical groups with hidden agendas. Transgenic plants have a
twenty-three year track record of success and safety which will
become progressively more difficult for opponents of genetic
engineering technology, to ignore. 
Transgenic plant releases and commercialization are gov-
erned by Draconian rules unparalleled elsewhere in any other
sector. The European Union in a report following a fifteen-year
study (1985-2000) involving 400 public research institutions, at
a cost of 70 million Euros stated “... genetically modified plants
and products derived from them present no risk to human
health or the environment......these crops and products are
even safer than plants and products generated through con-
ventional processes“ [39]. 
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